Champions Oncology

Champions Oncology was founded by some of the world’s most renowned specialists in the field of cancer diagnosis, treatment, and research. Our team is comprised of seasoned oncology professionals passionately dedicated to working with you to accelerate oncology drug development, improve outcomes and extend lives. Our core platform, the Champions TumorGraft™ offers an enhanced xenograft mouse avatar model for growing and testing human tumors.
Type
Public
HQ
Hackensack, US
Founded
2007
Size (employees)
60 (est)+6%
Champions Oncology was founded in 2007 and is headquartered in Hackensack, US

Key People at Champions Oncology

Joel Ackerman

Joel Ackerman

CEO
Ronnie Morris

Ronnie Morris

President
Scott Tobin

Scott Tobin

Director
Misti Ushio

Misti Ushio

Involved

Champions Oncology Office Locations

Champions Oncology has offices in Hackensack, Baltimore, London
Hackensack, US (HQ)
307 1 University Plaza Dr
London, GB
2 Royal College St
Baltimore, US
602 855 N Wolfe St

Champions Oncology Metrics

Champions Oncology Financial Metrics

Revenue (2016)

$11.2 m

Revenue growth (2015-16), %

26%

Net income (2016)

($10.4 m)

Market capitalization (21-Mar-2017)

$33 m

Closing share price (21-Mar-2017)

$3.1
Champions Oncology's current market capitalization is $33 m.
Champions Oncology's revenue was reported to be $11.2 m in FY, 2016 which is a 26.2% increase from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

$11.6 m$8.9 m$11.2 m

Revenue growth, %

(23%)26%

Operating expense total

$17.8 m$22.1 m$21.5 m

EBIT

($6.3 m)($13.2 m)($10.3 m)

EBIT margin, %

(54%)(149%)(92%)

Net Income

($7.4 m)($13.1 m)($10.4 m)
FY, 2014FY, 2015FY, 2016

Cash

$5.9 m$9.4 m

Accounts Receivable

$1.3 m$1.1 m$1.3 m

Inventories

$383 k$346 k$443 k

Current Assets

$7.6 m$10.8 m$4.3 m

PP&E

$434 k$452 k$618 k

Goodwill

$669 k$669 k$669 k

Total Assets

$8.9 m$12 m$5.8 m

Accounts Payable

$981 k$1.4 m$1.9 m

Current Liabilities

$3.7 m$3.8 m$5.3 m

Additional Paid-in Capital

$43.3 m$61.2 m$63.9 m

Retained Earnings

($38.9 m)($52 m)($62.5 m)

Total Equity

$3.2 m$8.1 m$238 k

Financial Leverage

2.8 x1.5 x24.3 x
FY, 2014FY, 2015FY, 2016

Net Income

($7.4 m)($13.1 m)($10.4 m)

Depreciation and Amortization

$213 k$214 k$156 k

Accounts Receivable

($825 k)$265 k($282 k)

Inventories

Accounts Payable

($223 k)$433 k$482 k

Cash From Operating Activities

($3.4 m)($9.6 m)($6.5 m)

Purchases of PP&E

($234 k)($119 k)($322 k)

Cash From Investing Activities

($234 k)($114 k)($322 k)

Champions Oncology Market Value History

Champions Oncology Online Presence

Champions Oncology Company Life

You may also be interested in